SCHEDULE: CASI Pharmaceuticals Insider Boosts Stake

Huiying Memorial Foundation, affiliated with Dr. Wei-Wu He, increased its stake in CASI Pharmaceuticals by purchasing 230,000 ordinary shares.

Summary

• Huiying Memorial Foundation, a 501(c)(3) private family foundation, purchased 230,000 Ordinary Shares of CASI Pharmaceuticals, Inc. on the open market.
• The total cost of this purchase was $469,752, with an average per share price of US$2.0424.
• The funds used for the purchase were personal funds of Huiying Memorial Foundation.
• Following this transaction, Dr. Wei-Wu He, Ph.D., beneficially owns an aggregate of 3,965,535 Ordinary Shares, representing 19.1% of the class.
• Huiying Memorial Foundation beneficially owns 637,644 Ordinary Shares, representing 3.1% of the class.
• The percentage of ownership is calculated based on 20,548,273 Ordinary Shares outstanding as of September 30, 2025.

Sentiment

Score: 7

Explanation: The sentiment is positive due to an insider-affiliated entity increasing its stake, indicating confidence in the company's value. No negative information was disclosed.

Positives

• An affiliated entity, Huiying Memorial Foundation, increased its stake in the company, signaling confidence from insiders.
• The purchase was made on the open market, indicating a belief in the current valuation or future prospects of the shares.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on the change in beneficial ownership.

Industry Context

This filing is a routine disclosure of a change in beneficial ownership by an insider-affiliated entity. It does not provide broader industry context or competitive analysis.

Related Party Transactions

• Huiying Memorial Foundation, a 501(c)(3) private family foundation, purchased shares. Dr. Wei-Wu He, a reporting person, is an officer and a board member of the foundation, and a family member is also on the board. While Dr. He disclaims beneficial ownership of the foundation's shares, the transaction involves an entity closely associated with a key insider.

Stakeholder Impact

• Shareholders may view the increased insider-affiliated ownership as a positive signal of management's belief in the company's future, potentially bolstering investor confidence.
• The transaction itself does not directly impact employees, customers, suppliers, or creditors.

Key Dates

Recommendation

The insider-affiliated purchase is a positive signal, suggesting confidence from those closest to the company. However, this filing alone does not provide sufficient fundamental information (e.g., financial performance, strategic developments) to warrant a 'buy' recommendation. It primarily indicates a belief in the current or future value by an informed party, which supports holding the stock if already owned, but further analysis of the company's financials and strategic direction would be needed for a stronger recommendation.

Keywords

CASI Pharmaceuticals, Schedule 13D/A, Beneficial Ownership, Insider Buying, Share Purchase, Huiying Memorial Foundation, Wei-Wu He, Ordinary Shares